Incidence and distribution of HER2-positive gastric and gastroesophageal junction (GEJ) adenocarinomas in British Columbia (BC)

被引：0
|
作者：
Lim, H. J.
Aubin, F.
Kollmannsberger, C. K.
Huntsman, D.
Carter, B.
Zhou, C.
Woods, R.
Gill, S.
机构：
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[2] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[3] British Columbia Canc Agcy, Vancouver Canc Ctr, Vancouver, BC V5Z 4E6, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.91
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
91
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Incidence and distribution of HER2-positive gastric and gastroesophageal junction (GEJ) adenocarinomas in British Columbia (BC).
    Lim, H. J.
    Aubin, F.
    Zhou, C.
    Kollmannsberger, C. K.
    Woods, R.
    Carter, B.
    Huntsman, D.
    Gill, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Advances in the Management of HER2-positive Advanced Gastric and Gastroesophageal Junction Cancer
    Bang, Yung-Jue
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2012, 46 (08) : 637 - 648
  • [3] Herceptin in metastatic HER2-positive gastric cancer - GEJ approved
    Jelitto, H. -U.
    VISZERALMEDIZIN, 2010, 26 (02): : 141 - 141
  • [4] Phase II study of SHR1210 and trastuzumab in combination with CAPOX for neoadjuvant treatment of HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma
    Li, Ning
    Li, Zhi
    Fu, Qiang
    Zhang, Bin
    Zhang, Jian
    Wan, XiangBin
    Lu, Chaomin
    Wang, Jinbang
    Deng, Wenying
    Wei, Chen
    Ma, Yijie
    Bie, Liangyu
    Wang, Mengyu
    Luo, Suxia
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [5] Trastuzumab a new treatment option for HER2-positive metastatic gastric and gastroesophageal junction cancer
    Lordick, Florian
    FUTURE ONCOLOGY, 2011, 7 (02) : 187 - 199
  • [6] Combination of cinrebafusp alfa with ramucirumab and paclitaxel is well tolerated and elicits encouraging clinical activity in patients with HER2-positive gastric/gastroesophageal junction (GEJ) adenocarcinoma
    Ku, Geoffrey
    Lee, Jeeyun
    Aviano, Kayti
    Demuth, Tim
    Hasenkamp, Laura-Carolin
    Olwill, Shane A.
    CANCER RESEARCH, 2023, 83 (08)
  • [7] First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer
    Esen, Selin Akturk
    Ergun, Yakup
    Erol, Cihan
    Arikan, Rukiye
    Er, Muhammed Muhiddin
    Atci, Muhammed Mustafa
    Topcu, Atakan
    Ucar, Gokhan
    Akagunduz, Baran
    Aykan, Musa Baris
    Ozen, Mirac
    Baytemur, Naziyet Kose
    Ozcelik, Melike
    Sahin, Elif
    Guven, Denizcan
    Menekse, Serkan
    Ak, Naziye
    Teker, Fatih
    Kut, Engin
    Sakalar, Teoman
    Alan, Ozkan
    Kacan, Turgut
    Turhal, Nazim Serdar
    Kilickap, Saadettin
    Turker, Sema
    Sendur, Mehmet Ali Nahit
    Kostek, Osman
    Karaagac, Mustafa
    Sakin, Abdullah
    Turk, Haci Mehmet
    Caglayan, Dilek
    Cihan, Sener
    Acikgoz, Yusuf
    Uncu, Dogan
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2022, 22 (05) : 818 - 825
  • [8] Clinicopathologic features and treatment outcomes of patients (pts) with HER2-positive (pos) adenocarcinomas (ACA) of the esophagus (E) and gastroesophageal junction (GEJ)
    Phillips, B. E.
    Tubbs, R. R.
    Rice, T. W.
    Rybicki, L. A.
    Plesec, T.
    Rodriguez, C. P.
    Videtic, G. M.
    Saxton, J. P.
    Ives, D. I.
    Adelstein, D. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Clinicopathologic features and treatment outcomes of patients (pts) with HER2-positive (pos) adenocarcinomas (ACA) of the esophagus (E) and gastroesophageal junction (GEJ)
    Phillips, B. E.
    Tubbs, R. R.
    Rice, T. W.
    Rybicki, L. A.
    Plesec, T.
    Rodriguez, C. P.
    Videtic, G. M.
    Saxton, J. P.
    Ives, D. I.
    Adelstein, D. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [10] Clinicopathological characteristics of patients with HER2-positive gastric and gastroesophageal junction cancer in a single tertiary hospital.
    Camarin Sanchez, Efrain Isaias
    Enciso Lopez, Ervin Saul
    Rodriguez, Benigno
    Villegas Osorno, Diana Alejandra
    Villamayor, Omar Serrano
    Gerson, Daniela Shveid
    Martinez-Herrera, Jose Fabian
    Lopez Zepeda, Lorena
    Gerson, Raquel
    Olivares, Guillermo
    Villalobos, Alberto
    Regalado Porras, Gabriela Olivia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345